T
16.35
-0.04 (-0.24%)
前收盘价格 | 16.39 |
收盘价格 | 16.80 |
成交量 | 1,373,485 |
平均成交量 (3个月) | 1,655,295 |
市值 | 1,122,257,536 |
预期市盈率 (P/E Forward) | 1.11 |
价格/销量 (P/S) | 1.14 |
股市价格/股市净资产 (P/B) | 4.14 |
52周波幅 | |
利润日期 | 30 Apr 2025 |
营业毛利率 | -10.21% |
营业利益率 (TTM) | -0.21% |
稀释每股收益 (EPS TTM) | -1.47 |
季度收入增长率 (YOY) | 43.60% |
总债务/股东权益 (D/E MRQ) | 181.82% |
流动比率 (MRQ) | 2.93 |
营业现金流 (OCF TTM) | 24.23 M |
杠杆自由现金流 (LFCF TTM) | 38.15 M |
资产报酬率 (ROA TTM) | -6.45% |
股东权益报酬率 (ROE TTM) | -33.30% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (US) | 混合的 | 混合的 |
Medical Devices (全球的) | 混合的 | 混合的 | |
股票 | Tandem Diabetes Care, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
1.8
分析师共识 | 1.0 |
内部交易活动 | NA |
价格波动 | 3.0 |
技术平均移动指标 | 3.5 |
技术振荡指标 | -0.5 |
平均 | 1.75 |
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Small Growth |
内部持股比例 | 0.83% |
机构持股比例 | 108.98% |
52周波幅 | ||
目标价格波幅 | ||
高 | 63.00 (Canaccord Genuity, 285.32%) | 购买 |
中 | 24.00 (46.79%) | |
低 | 20.00 (Mizuho, 22.32%) | 保留 |
平均值 | 33.70 (106.12%) | |
总计 | 4 购买, 6 保留 | |
平均价格@调整类型 | 20.78 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Baird | 01 May 2025 | 24.00 (46.79%) | 保留 | 16.57 |
27 Feb 2025 | 33.00 (101.83%) | 保留 | 21.75 | |
Piper Sandler | 01 May 2025 | 30.00 (83.49%) | 购买 | 16.57 |
Mizuho | 10 Apr 2025 | 20.00 (22.32%) | 保留 | 17.04 |
Morgan Stanley | 05 Mar 2025 | 22.00 (34.56%) | 保留 | 19.11 |
Citigroup | 04 Mar 2025 | 24.00 (46.79%) | 保留 | 19.49 |
Goldman Sachs | 03 Mar 2025 | 24.00 (46.79%) | 保留 | 20.78 |
Wells Fargo | 03 Mar 2025 | 22.00 (34.56%) | 保留 | 20.78 |
Barclays | 28 Feb 2025 | 53.00 (224.16%) | 购买 | 22.14 |
RBC Capital | 27 Feb 2025 | 55.00 (236.39%) | 购买 | 21.75 |
Canaccord Genuity | 26 Feb 2025 | 63.00 (285.32%) | 购买 | 33.59 |
显示更多 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合